Similar articles

• Effect of 450-mg loading dose of clopidogrel on platelet function in Japanese patients undergoing coronary stent placement.

  Fukushima K, Kobayashi Y, Kitahara H, Iwata Y, Kuroda N, Ooyama M, Nomura F, Komuro I. Fukushima K, et al. Heart Vessels. 2010 May;25(3):182-6. doi: 10.1007/s00380-009-1190-x. Epub 2010 May 29. Heart Vessels. 2010. PMID: 20512444
• Relation of body mass index to high on-treatment platelet reactivity and of failed clopidogrel dose adjustment according to platelet reactivity monitoring in patients undergoing percutaneous coronary intervention.

  Bonello-Palot N, Armero S, Paganelli F, Mancini J, De Labriolle A, Bonello C, Lévy N, Maillard L, Barragan P, Dignat-George F, Camoin-Jau L, Bonello L. Bonello-Palot N, et al. Am J Cardiol. 2009 Dec 1;104(11):1511-5. doi: 10.1016/j.amjcard.2009.07.015. Am J Cardiol. 2009. PMID: 19932784
• Reasons for inability of clopidogrel to inhibit platelet aggregation early after coronary artery bypass surgery.

  Raja SG. Raja SG. J Thorac Cardiovasc Surg. 2005 Feb;129(2):475; author reply 475-6. doi: 10.1016/j.jtcvs.2004.09.027. J Thorac Cardiovasc Surg. 2005. PMID: 15678077 No abstract available.
• Clopidogrel pretreatment in PCI: absolute requirement or obsolete myth?

  Alexopoulos D. Alexopoulos D. Int J Cardiol. 2011 Feb 3;146(3):305-10. doi: 10.1016/j.ijcard.2010.06.019. Epub 2010 Jul 7. Int J Cardiol. 2011. PMID: 20615559 Review.
• The benefits of abciximab questioned in percutaneous coronary interventions following pretreatment with high-dose clopidogrel.

  Salam AM. Salam AM. Expert Opin Investig Drugs. 2005 Mar;14(3):335-8. doi: 10.1517/13543784.14.3.335. Expert Opin Investig Drugs. 2005. PMID: 15833064 Review. No abstract available.